3-186722440-A-T

Position:

• chr3-186722440-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2 BP4

The NM_001102416.3(KNG1):​c.310A>T​(p.Thr104Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency: Genomes: not found (cov: 32)
• Consequence: KNG1 NM_001102416.3 missense
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: 1.62

Genes affected

KNG1 (HGNC:6383): (kininogen 1) This gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system. Also, bradykinin, a peptide causing numerous physiological effects, is released from HMWK. Bradykinin also functions as an antimicrobial peptide with antibacterial and antifungal activity. In contrast to HMWK, LMWK is not involved in blood coagulation. Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reduces or depletes angiotensin converting enzyme 2 (ACE2), which results in an increase in levels of des-Arg(9)-bradykinin, a bioactive metabolite of bradykinin that is associated with lung injury and inflammation. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2020]

HRG-AS1 (HGNC:55915): (HRG and FETUB antisense RNA 1)

ACMG classification

Verdict is Uncertain_significance. Variant got 1 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.27912176).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
KNG1	NM_001102416.3	c.310A>T	p.Thr104Ser	missense_variant	3/10	ENST00000644859.2	NP_001095886.1
KNG1	NM_000893.4	c.310A>T	p.Thr104Ser	missense_variant	3/11		NP_000884.1
KNG1	NM_001166451.2	c.310A>T	p.Thr104Ser	missense_variant	3/10		NP_001159923.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
KNG1	ENST00000644859.2	c.310A>T	p.Thr104Ser	missense_variant	3/10		NM_001102416.3	ENSP00000493985
HRG-AS1	ENST00000630178.2	n.136-3871T>A		intron_variant, non_coding_transcript_variant		5

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 29

GnomAD4 genome Cov.: 32

ClinVar

Significance: Uncertain significance

Submissions summary: Uncertain:1

Revision: criteria provided, single submitter

Submissions by phenotype

not specified Uncertain:1

Uncertain significance, criteria provided, single submitter

clinical testing

Ambry Genetics

Oct 10, 2023

The c.310A>T (p.T104S) alteration is located in exon 3 (coding exon 3) of the KNG1 gene. This alteration results from a A to T substitution at nucleotide position 310, causing the threonine (T) at amino acid position 104 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.14
BayesDel_addAF	Benign	-0.20	T
BayesDel_noAF	Benign	-0.52
CADD	Benign	19
DANN	Uncertain	0.99
DEOGEN2	Benign	0.31	.;T;.;.;T
Eigen	Benign	0.012
Eigen_PC	Benign	-0.042
FATHMM_MKL	Benign	0.57	D
LIST_S2	Benign	0.83	.;.;T;T;T
M_CAP	Benign	0.010	T
MetaRNN	Benign	0.28	T;T;T;T;T
MetaSVM	Benign	-0.98	T
MutationAssessor	Uncertain	2.3	M;M;M;M;M
MutationTaster	Benign	0.62	N;N;N
PrimateAI	Benign	0.37	T
PROVEAN	Benign	-2.3	.;N;N;D;.
REVEL	Benign	0.069
Sift	Benign	0.14	.;T;T;T;.
Sift4G	Uncertain	0.011	.;D;D;D;.
Polyphen		0.75	P;P;.;P;P
Vest4		0.17, 0.26, 0.24
MutPred		0.37		Gain of glycosylation at T104 (P = 0.015);Gain of glycosylation at T104 (P = 0.015);Gain of glycosylation at T104 (P = 0.015);Gain of glycosylation at T104 (P = 0.015);Gain of glycosylation at T104 (P = 0.015);
MVP		0.44
MPC		0.095
ClinPred		0.89	D
GERP RS		3.2
Varity_R		0.080
gMVP		0.25

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-186440229;